Publications found:
43,607
Sort by:
Inovative Yersinia Diagnostic Technologies and Emerging Markets
US$ 3,080.00
The report contains 197 pages, 8 tables and presents a detailed analysis of the Yersinia diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Yersinia definition, epidemiology and etiology are reviewed. The report provides the 5- ...
November 2012
197 pages
Innovative Alpha-2 Antiplasmin Diagnostic Testing Technologies and Emerging Markets
US$ 3,080.00
... products and services. Moreover, the continuing contraction of the hospital system and technological advances will facilitate decentralization of the Alpha-2 Antiplasmin testing closer to the patient, creating additional opportunities and challenges for suppliers. The report examines market applications of ...
November 2012
195 pages
Innovative Antithrombin III Diagnostic Testing Technologies and Emerging Markets
US$ 3,080.00
... products and services. Moreover, the continuing contraction of the hospital system and technological advances will facilitate decentralization of the AT III testing closer to the patient, creating additional opportunities and challenges for suppliers. The report examines market applications of chromogenic ...
November 2012
197 pages
Innovative APTT Diagnostic Testing Technologies and Emerging Markets
US$ 3,080.00
... opportunities for quality control products and services. Moreover, the continuing contraction of the hospital system and technological advances will facilitate decentralization of the APTT testing closer to the patient, creating additional opportunities and challenges for suppliers. The report examines ...
November 2012
198 pages
Innovative D-Dimer Diagnostic Testing Technologies and Emerging Markets
US$ 3,080.00
... opportunities for quality control products and services. Moreover, the continuing contraction of the hospital system and technological advances will facilitate decentralization of the D-Dimer testing closer to the patient, creating additional opportunities and challenges for suppliers. The report examines ...
November 2012
197 pages
Innovative Factor Assays Diagnostic Testing Technologies and Emerging Markets
US$ 3,800.00
... nations and continued technological advances will radically change coagulation testing practice during the next ten years. New specific and ... system and technological advances will facilitate decentralization of the Factor Assays testing closer to the patient, creating additional opportunities and challenges ...
November 2012
295 pages
Innovative Fibrinogen Diagnostic Testing Technologies and Emerging Markets
US$ 3,080.00
... for quality control products and services. Moreover, the continuing contraction of the hospital system and technological advances will facilitate decentralization of the Fibrinogen testing closer to the patient, creating additional opportunities and challenges for suppliers. The report examines market ...
November 2012
200 pages
Innovative Heparin Diagnostic Testing Technologies and Emerging Markets
US$ 3,080.00
... opportunities for quality control products and services. Moreover, the continuing contraction of the hospital system and technological advances will facilitate decentralization of the Heparin testing closer to the patient, creating additional opportunities and challenges for suppliers. This report presents ...
November 2012
200 pages
Innovative Proteins C and S Diagnostic Testing Technologies and Emerging Markets
US$ 3,080.00
... next ten years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Coagulation testing in general, and Proteins C and S testing specifically, will become more standardized, offering opportunities for quality control products and services. Moreover, the ...
November 2012
194 pages
Innovative PT Diagnostic Testing Technologies and Emerging Markets
US$ 3,080.00
... , and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks. Contains 200 pages and 8 ...
November 2012
200 pages
Innovative Thrombin Time Diagnostic Testing Technologies and Emerging Markets
US$ 3,080.00
... nations and continued technological advances will radically change coagulation testing practice during the next ten years. New specific and ... system and technological advances will facilitate decentralization of the Thrombin Time testing closer to the patient, creating additional opportunities and challenges ...
November 2012
196 pages
Innovative AFP Testing Technologies and Emerging Markets
US$ 3,080.00
... , and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks. Contains 248 pages and 14 ...
November 2012
248 pages
Innovative Beta-2 Microglobulin Testing Technologies and Emerging Markets
US$ 3,080.00
This report contains 243 pages, 9 tables and presents a detailed analysis of the ß-2 Microglobulin testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; 5- and 10-year test volume and sales forecasts by country and ...
November 2012
243 pages
Innovative CA Tumor Marker Tests Technologies and Emerging Markets
US$ 3,880.00
... and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for ...
November 2012
278 pages
Innovative CEA Testing Technologies and Emerging Markets
US$ 3,080.00
... , and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks. Contains 250 pages and 15 ...
November 2012
250 pages
Innovative Occult Blood Testing Technologies and Emerging Markets
US$ 3,080.00
... contains 243 pages, 8 tables and presents a detailed analysis of the Occult Blood testing market in the US, Europe (France, Germany, Italy, Spain, UK) and ... disease. During the next ten years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated ...
November 2012
243 pages
Innovative Pap Smear/HPV Testing Technologies and Emerging Markets
US$ 3,080.00
... 243 pages, 7 tables and presents a detailed analysis of the Pap Smear/HPV testing market in the US, Europe (France, Germany, Italy, Spain, ... analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies ...
November 2012
243 pages
Innovative Prostatic Acid Phosphatase Testing Technologies and Emerging Markets
US$ 3,080.00
... , and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks. Contains 242 pages and 11 ...
November 2012
242 pages
Innovative PSA Testing Technologies and Emerging Markets
US$ 3,080.00
... , and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks. Contains 249 pages and 15 ...
November 2012
249 pages
Innovative Blood Banking Technologies and Emerging Markets
US$ 19,040.00
... potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next ten years, and to assist ... where product positioning and differentiation are more critical than underlying technology. The changes in the marketplace will create exciting opportunities for ...
November 2012
800 pages
Innovative Cancer Diagnostic Technologies and Emerging Markets
US$ 18,960.00
... market players and potential entrants; and suggests alternative business expansion strategies for suppliers. The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the ...
November 2012
1200 pages
Innovative Coagulation Testing Technologies and Emerging Markets
US$ 19,120.00
... , offering opportunities for quality control products and services. Moreover, continuing contraction of the hospital system and technological advances will facilitate decentralization of the coagulation testing closer to the patient, thus creating additional opportunities and challenges for suppliers.
November 2012
650 pages
Innovative Infectious Disease Testing Technologies and Emerging Markets
US$ 19,120.00
... contributing to the rise in incidence of opportunistic infections, threat of bioterrorism, advances in molecular diagnostic technologies, and a wider availability of immunosuppressive drugs. The infectious disease testing market is one of the most rapidly growing segments of the in vitro diagnostics industry ...
November 2012
1900 pages
Innovative Molecular Diagnostic Technologies and Emerging Markets
US$ 19,040.00
... entrants identify and evaluate major business opportunities emerging in the molecular diagnostics market during this decade. The report explores business and technological trends in the US, five major European countries, (France, Germany, Italy, Spain, UK) and Japan; ...
November 2012
1050 pages
EEG/EMG/Brain Function Monitoring: Market Research Report
US$ 4,950.00
This report analyzes the worldwide markets for EEG/EMG/Brain Function Monitoring in US$ Million by the following Product Segments: Electroencephalograph Equipment, ... Nihon Kohden Corporation, Nihon Kohden America, Inc., and Noraxon U.S.A., Inc. Market data and analytics are derived from primary and secondary ...
October 2012
347 pages
KOL Insight: Hepatitis C: the Race for the First Interferon-free Regimen
US$ 7,495.00
... with the greatest insight into how HCV clinical research will shape the future market. Key Benefits Hepatitis C: the race for the first interferon-free regimen examines the most prominent insights gained from the ... generation protease inhibitors Develop planning strategies based on insight from the field’s foremost KOLs Identify the unmet needs and opportunities for ...
October 2012
246 pages
US Prenatal Testing Market Report: 2012 Edition
US$ 800.00
... posing acute challenges. This report provides a comprehensive overview of the US prenatal testing market covering the market opportunity for the T21 tests. The prenatal testing realm is getting intensely ...
October 2012
42 pages
Analysis of Blood Banking Instrumentation And Strategic Profiles of Leading Suppliers
US$ 2,800.00
This 68-page report reviews current instrumentation technologies, and compares features of leading blood banking automated and semi-automated analyzers. The report also presents strategic assessments of current and emerging suppliers of blood banking products, including their sales, product portfolios, ...
September 2012
68 pages
Analysis of Blood Banking Technologies And Strategic Profiles of Leading Suppliers
US$ 2,800.00
... The report also presents strategic assessments of current and emerging suppliers of blood banking products, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Contains 114 pages
September 2012
114 pages
Analysis of Cancer Diagnostic Technologies And Strategic Profiles of Leading Suppliers
US$ 2,800.00
... as monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, flow cytometry, biosensors, and their potential applications for cancer diagnostic testing. Also included is a review of competing/complementing technologies, such as CT, MRI, NMR, PET and photonics ...
September 2012
185 pages
Analysis of Molecular Diagnostics Instrumentation And Strategic Profiles of Leading Suppliers
US$ 2,800.00
... DNA extractors, DNA synthesizers, thermal cyclers, robotic work-stations, and automated DNA probe analysis systems. The report reviews current instrumentation technologies, and compares features of leading molecular diagnostics analyzers marketed by Abbott, Beckman Coulter, BD, Bio-Rad, Gen-Probe, Tecan, ...
September 2012
103 pages
Analysis of Emerging Immunodiagnostic Tests And Strategic Profiles of Leading Suppliers
US$ 3,160.00
... of companies developing or marketing new technologies and products. The report also presents strategic assessments of current and emerging suppliers of clinical chemistry and immunodiagnostic products, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new ...
September 2012
240 pages
Analysis of Emerging Hemostasis Tests And Strategic Profiles of Leading Suppliers
US$ 2,800.00
... . The report also includes strategic assessments of current and emerging suppliers of hemostasis diagnostic products, including marketing tactics, technological know-how ... pages and 19 tables Synopsis "This 165-page report presents the clinical significance and market needs for major hemostasis laboratory ...
September 2012
165 pages
Analysis of Emerging Microbiology Tests and Strategic Profiles of Leading Suppliers
US$ 2,800.00
... of companies developing or marketing innovative technologies and products. The report also presents strategic assessments of leading market players and emerging suppliers with innovative technologies and products, including their sales, product portfolios, distribution tactics, technological know-how, new ...
September 2012
760 pages
US Market Changes in the Treatment of Advanced Prostate Cancer
US$ 2,900.00
Progressively unfolding patient case scenarios were presented to 151 U.S. oncologists in a survey for their open-ended responses providing rich insight into their clinical decisions. Data includes specific treatment choices, factors that influence their decisions, barriers to optimal treatment and confidence ...
September 2012
30 pages
US Market Changes in the Treatment of Advanced Melanoma
US$ 2,900.00
... regimen choices, factors that influence their decisions, barriers to optimal patient care and confidence in patient treatment. This report identifies market changes based on a comparison of physician practice patterns from 2011 and 2012 and provides actionable data for developing marketing strategies.
September 2012
31 pages